Colorado-based DaVita HealthCare Partners’ dialysis division has entered into a joint venture (JV) agreement with Xiaoyi Zhang, president of Shunjing Renal Hospital to establish a kidney care speciality hospital chain in the Shandong province of China.

The agreement establishes DaVita (Shandong) Kidney Disease Hospital as a first-of-its-kind renal dialysis JV between a multinational healthcare provider and the private sector in China.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Shunjing Renal Hospital is the only facility in Shandong province’s capital of Jinan that is approved for dialysis services.

DaVita international operations CEO Dennis Kogod said: "DaVita has the potential to significantly raise the quality of kidney care services available in this region of China.

"The new hospital chain we are creating is a major step in that direction."

"DaVita has the potential to significantly raise the quality of kidney care services available in this region of China."

Zhang, who will be the CEO of DaVita (Shandong) Kidney Disease Hospital, said: "We will incorporate DaVita’s advanced concepts and technologies in healthcare management with our experience in operating hospitals in the local market.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"This is a win-win for end-stage renal disease patients as we build a Sino-US joint venture flagship hospital starting in Jinan City and eventually across Shandong province."

Recent studies showed that the number of people living with chronic kidney disease (CKD) in China could be as many as 120 million, and that only 12% of these are aware of their condition.

DaVita Asia-Pacific region president Atul Mathur said: "Chronic kidney disease is a growing health issue in China.

"DaVita [Shandong] Kidney Disease Hospital directly addresses this problem. By expanding services available, we’ll be helping many patients to live better quality lives."

In August, DaVita HealthCare Partners signed a $415m deal to acquire US-based Renal Ventures, an operator of 36 dialysis clinics in six states.

The company’s divisions, including Multispecialty Physician Partners and Physician Venture Partners, operate infusion and vascular centres in three states.